Rojas Carlos Rodríguez, Santamaría Celia Juez, Pons Belda Oscar David, Noguero Emilia Moreno
Clinical Analyses Department, Hospital Can Misses, Eivissa, Spain.
Pharmacy Department, Hospital Can Misses, Eivissa, Spain.
EJIFCC. 2023 Oct 16;34(3):258-261. eCollection 2023 Oct.
Serum index and macroscopic characteristics of samples can give valuable information and should be interpreted as a result. Following centrifugation of the sample, on gross inspection it was observed that the serum had a brown color. After ruling out the main causes that can cause a brown coloration, such as intravascular hemolysis or high concentrations of methemoglobin, it was noted that the patient was receiving a high-dose of Eltrombopag therapy. Eltrombopag is a non-peptide thrombopoietin receptor agonist approved for the treatment of severe aplastic anemia (SAA). The drug in solution has a brown color and at high concentrations it is capable of changing the color of the serum and may have different effects in different assays of laboratory. This article describes the case of a patient with brown serum due to the consumption of high doses of Eltrombopag that started to cause cutaneous hyperpigmentation.
血清指标和样本的宏观特征能够提供有价值的信息,应将其作为结果进行解读。样本离心后,肉眼观察发现血清呈棕色。在排除了可导致棕色的主要原因,如血管内溶血或高铁血红蛋白浓度过高后,注意到该患者正在接受大剂量的艾曲泊帕治疗。艾曲泊帕是一种非肽类血小板生成素受体激动剂,被批准用于治疗重型再生障碍性贫血(SAA)。该药物溶液呈棕色,高浓度时能够改变血清颜色,并且在不同的实验室检测中可能产生不同的影响。本文描述了一例因服用高剂量艾曲泊帕导致血清棕色并开始出现皮肤色素沉着的患者病例。